European markets move higher; Renault shares up 6% after quarterly revenue jump

European markets move higher; Renault shares up 6% after quarterly revenue jump


European stocks were slightly higher on Thursday, as investors reviewed another batch of earnings reports, and as U.S. market declines weighed on global sentiment.

The pan-European Stoxx 600 was up 0.53% by 10:05 a.m. London time, with the majority of major bourses and sectors trading in positive territory. Travel and leisure stocks added 2.85% while retail shares were the sole outlier, dipping 0.23%.

Shares of Renault jumped more than 7% after the French carmaker reported an unexpected uptick in third-quarter revenue amid strong demand for its pricier models. The stock was last seen up 6.3%.

Barclays shares also rose 4% after the British bank reported better-than-expected third-quarter results.

Meanwhile, Hermes added 2.3%, before paring gains slightly, after the French fashion house reported an increase in third quarter sales, as demand for its Birkin bags continue to outweigh a wider downturn in luxury sales. Shares were last seen up 1.9%.

The return to positive sentiment comes after U.S. markets declined on Wednesday. The Dow ended the session with its biggest one-day loss since early September, dropping more than 400 points, or 0.96%. The S&P 500 slipped 0.92%, while the Nasdaq Composite fell 1.6%. It was the third straight losing day for the Dow and the S&P 500.

The declines prompted Asia-Pacific markets to mostly fall overnight. U.S. stock futures linked to the S&P 500 traded near the flatline.

— CNBC’s Lisa Kailai Han contributed to this market summary



Source

Merck shells out  billion for London-based lung therapy firm Verona
World

Merck shells out $10 billion for London-based lung therapy firm Verona

Bloomberg | Bloomberg | Getty Images Merck will buy UK-based Verona Pharma for about $10 billion, the companies said on Wednesday, strengthening the U.S. firm’s respiratory treatment portfolio in a bid to diversify its revenue source beyond blockbuster cancer drug. Merck has been leaning on its aging cancer immunotherapy Keytruda, the world’s top-selling prescription medicine, […]

Read More
Singapore state investor Temasek is rethinking defense as a strategic ESG bet
World

Singapore state investor Temasek is rethinking defense as a strategic ESG bet

Defense stocks are booming — and according to one of Asia’s biggest investors, allocating capital to the sector doesn’t mean having to abandon ESG initiatives. Speaking to CNBC’s Martin Soong on Wednesday, Rohit Sipahimalani, chief investment officer at Singapore’s state investment fund Temasek, said his team were looking at opportunities in the European defense sector. […]

Read More
Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push
World

Shares of Ray-Ban maker EssilorLuxottica jump 6% on reported Meta stake in AI push

Smart Ray-Ban Glasses, on June 16, 2024, in Caen, Normandy, France. Nurphoto | Getty Images Shares of Ray-Ban maker EssilorLuxottica almost 6% on Wednesday on reports that Meta has taken a minority stake in the company amid growing appetite for AI-powered wearable devices. Meta reportedly bought a stake worth around 3 billion euros ($3.51 billion) […]

Read More